Robeco Institutional Asset Management B.V. Moderna, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$46 Billion
Q2 2024

A detailed history of Robeco Institutional Asset Management B.V. transactions in Moderna, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 90,348 shares of MRNA stock, worth $5.94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

90,348

Previous 82,848 9.05%

Holding current value

$5.94 Million

Previous $8.83 Million 21.52%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$101.21 - $166.61 $759,075 - $1.25 Million	7,500 Added 9.05%	90,348 $10.7 Million
Q1 2024 Apr 24, 2024	SELL	$85.37 - $115.44 $996,780 - $1.35 Million	-11,676 Reduced 12.35%	82,848 $8.83 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $1.78 Million - $2.68 Million	25,635 Added 37.21%	94,524 $9.4 Million
Q4 2023 Feb 08, 2024	SELL	$69.51 - $104.43 $5 Million - $7.51 Million	-71,939 Reduced 51.08%	68,889 $94.5 Million
Q3 2023 Oct 23, 2023	SELL	$96.41 - $126.61 $11.5 Million - $15.1 Million	-118,995 Reduced 45.8%	140,828 $14.5 Million
Q2 2023 Jul 24, 2023	SELL	$118.5 - $160.53 $2.67 Million - $3.62 Million	-22,532 Reduced 7.98%	259,823 $31.6 Million
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $905,394 - $1.31 Million	6,674 Added 2.42%	282,355 $43.4 Million
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $1.22 Million - $2.16 Million	10,307 Added 3.88%	275,681 $49.5 Million
Q3 2022 Dec 01, 2022	BUY	$118.07 - $194.18 $1.17 Million - $1.93 Million	9,936 Added 3.89%	265,374 $31.4 Million
Q3 2022 Oct 26, 2022	BUY	$118.07 - $194.18 $1.17 Million - $1.93 Million	9,936 Added 3.89%	265,374 $31.4 Million
Q2 2022 Dec 01, 2022	BUY	$117.13 - $176.59 $3.77 Million - $5.68 Million	32,177 Added 14.41%	255,438 $36.5 Million
Q2 2022 Jul 27, 2022	BUY	$117.13 - $176.59 $3.77 Million - $5.68 Million	32,177 Added 14.41%	255,438 $36.5 Million
Q1 2022 Dec 01, 2022	BUY	$126.46 - $235.05 $2.78 Million - $5.18 Million	22,022 Added 10.94%	223,261 $38.5 Million
Q1 2022 Apr 26, 2022	BUY	$126.46 - $235.05 $2.78 Million - $5.18 Million	22,022 Added 10.94%	223,261 $38.5 Million
Q4 2021 Dec 01, 2022	SELL	$225.82 - $368.51 $11.4 Million - $18.6 Million	-50,360 Reduced 20.02%	201,239 $51.1 Million
Q4 2021 Jan 31, 2022	SELL	$225.82 - $368.51 $11.4 Million - $18.6 Million	-50,360 Reduced 20.02%	201,239 $51.1 Million
Q3 2021 Dec 01, 2022	SELL	$221.9 - $484.47 $5.58 Million - $12.2 Million	-25,126 Reduced 9.08%	251,599 $96.8 Million
Q3 2021 Oct 20, 2021	SELL	$221.9 - $484.47 $5.58 Million - $12.2 Million	-25,126 Reduced 9.08%	251,599 $96.8 Million
Q2 2021 Dec 01, 2022	BUY	$129.91 - $234.98 $12.4 Million - $22.4 Million	95,419 Added 52.63%	276,725 $65 Million
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $12.4 Million - $22.4 Million	95,419 Added 52.63%	276,725 $65 Million
Q1 2021 Dec 01, 2022	SELL	$109.18 - $185.98 $9.18 Million - $15.6 Million	-84,068 Reduced 31.68%	181,306 $23.7 Million
Q1 2021 Apr 23, 2021	BUY	$109.18 - $185.98 $2.47 Million - $4.21 Million	22,615 Added 14.25%	181,306 $23.7 Million
Q4 2020 Dec 01, 2022	SELL	$65.74 - $169.86 $7.01 Million - $18.1 Million	-106,683 Reduced 40.2%	158,691 $16.6 Million
Q4 2020 Jan 28, 2021	BUY	$65.74 - $169.86 $844,233 - $2.18 Million	12,842 Added 8.8%	158,691 $16.6 Million
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $1.24 Million - $2.17 Million	22,880 Added 18.61%	145,849 $10.3 Million
Q2 2020 Jul 20, 2020	BUY	$29.67 - $80.0 $3.53 Million - $9.53 Million	119,138 Added 3109.84%	122,969 $7.9 Million
Q1 2020 Apr 30, 2020	BUY	$17.78 - $31.58 $68,115 - $120,982	3,831 New	3,831 $115,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Moderna, Inc. Transaction History